Commentary on: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies''
type: Item
instance of: scholarly article
title: Commentary on: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies''
zbMATH Open document ID: 1547.62542
author: Ying Yuan
author: Yixuan Zhao
published in: Statistics in Medicine
publication date: 2024-10-30T00:00:00Z
Mathematics Subject Classification ID: 62P10
zbMATH DE Number: 7935587
MaRDI profile type: MaRDI publication profile
cites work: Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
cites work: Bayesian optimal interval designs for phase I clinical trials
cites work: gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points
cites work: A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies
DOI: 10.1002/SIM.9496
description: scientific article; zbMATH DE number 7935587